Applying current smouldering myeloma risk models to a UK single-centre cohort and clinical features at progression. (2022)
Attributed to:
MICA: Optimising combination strategies for chimeric antigen receptor therapy in multiple myeloma
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bjh.17969
PubMed Identifier: 34812509
Publication URI: http://europepmc.org/abstract/MED/34812509
Type: Journal Article/Review
Volume: 196
Parent Publication: British journal of haematology
Issue: 6
ISSN: 0007-1048